| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |